Bio-gate AG (XETRA:BIG1) — Stock Price
Bio-gate AG (XETRA:BIG1) is currently trading at €3.28 EUR, down 2.24% today. Over the past 52 weeks, shares have ranged between €0.51 and €3.35. This page tracks Bio-gate AG's live share price on the XETRA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see BIG1 market cap overview.
Bio-gate AG (BIG1) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Bio-gate AG's daily closing share price and trading volume on the XETRA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Bio-gate AG Income Statement — Revenue, Profit & Earnings by Year
Bio-gate AG's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | €7.05 Million | €7.25 Million | €5.99 Million | €6.24 Million | €5.13 Million |
| Cost of Revenue | €2.92 Million | €3.37 Million | €2.41 Million | €2.41 Million | €2.06 Million |
| Gross Profit | €4.14 Million | €3.88 Million | €3.58 Million | €3.83 Million | €3.07 Million |
| Research & Development | — | — | — | — | — |
| SG&A | — | — | — | — | — |
| Total Operating Expenses | €8.66 Million | €8.84 Million | €7.77 Million | €6.77 Million | €5.95 Million |
| Operating Income | €-1.60 Million | €-1.59 Million | €-1.78 Million | €-534.85K | €-815.53K |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | — | — |
| Interest Expense | €55.81K | €47.80K | €23.08K | €23.27K | €22.02K |
| Income Before Tax | €-1.66 Million | €-1.64 Million | €-1.81 Million | €-559.88K | €-839.94K |
| Income Tax Expense | — | — | — | — | — |
| Net Income | €-1.62 Million | €-1.62 Million | €-1.81 Million | €-544.12K | €-804.88K |
Bio-gate AG Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Bio-gate AG's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | €3.95 Million | €5.26 Million | €6.22 Million | €5.21 Million | €3.31 Million |
| Total Current Assets | €2.25 Million | €3.37 Million | €4.21 Million | €3.60 Million | €2.04 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | €200.46K | €338.27K | €561.35K | €585.62K | €531.28K |
| Inventory | €1.57 Million | €1.24 Million | €1.85 Million | €845.43K | €782.53K |
| Property, Plant & Equipment | — | — | — | — | — |
| Goodwill | €0.00 | €0.00 | €0.00 | €0.00 | €0.00 |
| Total Liabilities | €2.16 Million | €1.81 Million | €1.97 Million | €1.44 Million | €1.76 Million |
| Total Current Liabilities | €1.06 Million | €967.87K | €1.19 Million | €832.26K | €1.12 Million |
| Long-term Debt | — | — | €0.00 | €45.85K | €86.27K |
| Net Debt | — | — | — | — | — |
| Total Stockholder Equity | €1.75 Million | €3.37 Million | €4.15 Million | €3.67 Million | €1.56 Million |
| Retained Earnings | €-13.52 Million | €-11.90 Million | €-10.27 Million | €-8.47 Million | €-7.92 Million |
Bio-gate AG Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Bio-gate AG generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-1.22 Million | €-977.00K | €-2.15 Million | €-634.00K | €-597.00K |
| Capital Expenditures | €106.00K | €145.00K | €445.00K | €538.00K | €107.00K |
| Free Cash Flow | €-1.32 Million | €-1.12 Million | €-2.60 Million | €-1.17 Million | €-704.00K |
| Investing Cash Flow | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | €304.00K | €267.00K | €239.00K | €193.00K | €298.00K |
| Change in Cash | €-1.03 Million | €-284.00K | €-355.00K | €1.55 Million | €-42.00K |
Bio-gate AG Earnings History — EPS Actual vs. Analyst Estimates
Track Bio-gate AG's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Feb 18, 2026 | — | — | — |
| Sep 08, 2025 | — | — | — |